GlaxoSmithKline Pharmaceuticals Limited (NSE:GLAXO)
India · Delayed Price · Currency is INR 2,680.00
-30.00 (-1.11%)
Nov 11, 2026, 1:05 PM IST
NSE:GLAXO Market Cap
NSE:GLAXO has a market cap or net worth of 454.15 billion as of November 10, 2026. Its market cap has increased by 5.53% in one year.
Market Cap
454.15B
Enterprise Value
432.36B
Revenue
41.59B
Global Rank
n/a
Country Rank
n/a
PE Ratio
39.50
ChartMarket Cap Chart
Since October 25, 2001, NSE:GLAXO's market cap has increased from 19.14B to 454.15B, an increase of 2,272.77%. That is a compound annual growth rate of 13.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 11, 2026 | 454.15B | 8.49% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Rubicon Research | 274.67B |
| Pfizer | 176.45B |
| CORONA Remedies | 149.30B |
| Marksans Pharma | 137.76B |
| Sanofi Consumer Healthcare India | 77.98B |
| Senores Pharmaceuticals | 53.20B |
| SMS Pharmaceuticals | 46.78B |
| Sai Parenteral's | 20.60B |